… suggest that patients with COVID-19 pneumonia be given immunotherapy treatment at the
time of diagnosis, in order to block the possibility of a subsequent cytokine storm. The early …

… in treatment of 21 patients with severe and critical COVID-19. … improved immediately after
the treatment with tocilizumab in … for treatment of the cytokine storm associated with COVID-19 (…

… Since accumulating evidence suggests that patients with COVID-19 viral pneumonia … and
cytokine storm, we treated under emergency/expanded use of the SCD two COVID-19 ARDS …

… The immune dysregulation in severe COVID-19 individuals was driven by IL-6 [12] and the
IL-6 … Therefore, IL-6 may be a potential target cytokine to treat COVID-19 related ARDS. …

… cytokine storm and the options to inhibit the cytokine storm, in … for the clinical diagnosis and
treatment of COVID-19. … type coronavirus infection causes an inflammatory cytokine storm …

… pulmonary/non-pulmonary organ damage (causation vs association), we would need: 1)
Clinical trial to determine how anti-cytokine therapy would affect the clinical outcome of COVID-…

… in COVID-19 Acute respiratory distress syndrome (ARDS) and robust cytokine storm are the
hallmark of severe COVID-19 … as IL-6 inhibitors, to treat COVID-19- associated inflammation. …

… and new or re-purposed anti-viral medicines, it remains of utmost importance to use the
knowledge at our disposal to treat those patients most at risk of dying from Covid-19-induced …

… treatments for cytokine storms and macrophage activation syndrome in autoimmune/autoinflammatory
diseases [18]; in the COVID-19 … ARDS, if appropriately timed [10, 19], 20]. On the …

… studies are needed to amplify the current evidence and provide definitive answers to
dilemmas regarding timing and type of anti-COVID-19 therapy particularly in severe patients. …